PlumX Metrics
Embed PlumX Metrics

18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling

Journal of Experimental Medicine, ISSN: 1540-9538, Vol: 211, Issue: 8, Page: 1673-1687
2014
  • 136
    Citations
  • 0
    Usage
  • 163
    Captures
  • 6
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Nitto Pharma Research: Industrial Applications of Functional Fatty Acids Produced by Gut Lactic Acid Bacteria

PR Newswire Nitto Pharma, Kyoto, Japan publishes the March 2019 issue of theNitto Pharma e-Bulletinoffering insights into the company's activities on probiotics research for healthcare.

Article Description

N-3 polyunsaturated fatty acids (PUFAs) have potential cardiovascular benefit, although the mechanisms underlying this effect remain poorly understood. Fat-1 transgenic mice expressing Caenorhabditis elegans n-3 fatty acid desaturase, which is capable of producing n-3 PUFAs from n-6 PUFAs, exhibited resistance to pressure overload-induced inflammation and fibrosis, as well as reduced cardiac function. Lipidomic analysis revealed selective enrichment of eicosapentaenoic acid (EPA) in fat-1 transgenic bone marrow (BM) cells and EPA-metabolite 18-hydroxyeicosapentaenoic acid (18-HEPE) in fat-1 transgenic macrophages. BM transplantation experiments revealed that fat-1 transgenic BM cells, but not fat-1 transgenic cardiac cells, contributed to the antiremodeling effect and that the 18- HEPE-rich milieu in the fat-1 transgenic heart was generated by BM-derived cells, most likely macrophages. 18-HEPE inhibited macrophage-mediated proinflammatory activation of cardiac fibroblasts in culture, and in vivo administration of 18-HEPE reproduced the fat-1 mice phenotype, including resistance to pressure overload-induced maladaptive cardiac remodeling. © 2014 Endo et al.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know